Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPTOMYCIN Cause Product use issue? 102 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Product use issue have been filed in association with DAPTOMYCIN (daptomycin). This represents 1.1% of all adverse event reports for DAPTOMYCIN.

102
Reports of Product use issue with DAPTOMYCIN
1.1%
of all DAPTOMYCIN reports
18
Deaths
43
Hospitalizations

How Dangerous Is Product use issue From DAPTOMYCIN?

Of the 102 reports, 18 (17.6%) resulted in death, 43 (42.2%) required hospitalization, and 4 (3.9%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAPTOMYCIN. However, 102 reports have been filed with the FAERS database.

What Other Side Effects Does DAPTOMYCIN Cause?

Off label use (791) Drug ineffective (658) Product use in unapproved indication (654) Eosinophilic pneumonia (575) Acute kidney injury (501) Blood creatine phosphokinase increased (461) Pyrexia (447) Eosinophilia (405) Rhabdomyolysis (383) Drug reaction with eosinophilia and systemic symptoms (307)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which DAPTOMYCIN Alternatives Have Lower Product use issue Risk?

DAPTOMYCIN vs DARATUMUMAB DAPTOMYCIN vs DARATUMUMAB\HYALURONIDASE-FIHJ DAPTOMYCIN vs DARBEPOETIN ALFA DAPTOMYCIN vs DARIDOREXANT DAPTOMYCIN vs DARIFENACIN HYDROBROMIDE

Related Pages

DAPTOMYCIN Full Profile All Product use issue Reports All Drugs Causing Product use issue DAPTOMYCIN Demographics